Lusaris Therapeutics, Inc.
Pharmaceutical company · Morrisville, North Carolina, United States
Lusaris Therapeutics, Inc. is a pharmaceutical company headquartered in Morrisville, North Carolina, United States. Its earliest recorded incorporation is in 2021. It has reported private securities offerings to the US SEC, most recently $60 million sold in a notice filed in 2022.
Lusaris Therapeutics at a glance
What does Lusaris Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $60.2 million sold (2022).
Frequently asked questions about Lusaris Therapeutics
Where is Lusaris Therapeutics headquartered?
Lusaris Therapeutics, Inc. is headquartered in Morrisville, North Carolina, United States.
What does Lusaris Therapeutics do?
Lusaris Therapeutics, Inc. is a pharmaceutical company.
When was Lusaris Therapeutics founded?
The earliest incorporation on record for Lusaris Therapeutics, Inc. is in 2021, according to public company registers.
Similar companies
- Liquidia CorpMorrisville, North Carolina, United States
- Furiex Pharmaceuticals, Inc.Morrisville, North Carolina, United States
- TearScience, Inc.Morrisville, North Carolina, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences